News | May 28, 2008

IGRT Plays Central Role in Prostate Cancer Treatment

May 28th, 2008—A new book, “Image-Guided Radiation Therapy of Prostate Cancer,” is reportedly the first book of its kind to provide information on recommended RT doses, fractionation schedules, target volume delineation and IGRT procedures and policies.

To date, the specific causes of prostate cancer remain unknown; however, among men, prostate cancer is the most common and the second leading cause of cancer death in the U.S. Surgery and radiation therapy are the two most common of the treatment options available.

The holy grail of radiation treatment is precision. That goal now seems closer than ever with new image-guided methods such as PET-CT, 4D-CT and IMRT, which have been shown to provide better targeting accuracy, allowing clinicians to safely increase the dosage administered without increasing toxicity to healthy tissue areas, said the company.

However, accurate dose delivery - as well as dose verification - can present technical challenges. New techniques such as in situ dosimetry, daily dose measurements, robot assisted bracytherapy, deformable registration and dose painting with intensity-modulated radiation therapy (IMRT) all show early promise. Their ongoing evolution ensures the dual prospect of lower toxicity levels and stronger more effective radiation doses coexisting within a successful treatment plan that still manages to deliver less side effects than conventional radiotherapy.

Although IGRT is still in its infancy, its use is more advanced in prostate cancer than other malignancies.

Edited by Richard Valicenti, M.D., Adam Dicker, M.D., and David Jaffray, M.D., the book provides disease stage-specific IGRT guidelines and step-by-step description of current techniques, providing information of critical importance to radiation oncologists, radiologists, urologists and other professionals working in the field.

For more information:

Related Content

Elekta Introduces Strategy for Precision Radiation Medicine at ASTRO 2018

Elekta SmartClinic is one of the key features in the Mosaiq Plaza suite of data-focused integrative oncology software

News | Radiation Therapy | October 30, 2018
At the American Society for Radiation Oncology (ASTRO) Annual Meeting, Oct. 21-24 in San Antonio, Elekta introduced the...
ViewRay and Miami Cancer Institute Host Symposium on MR-Guided Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | October 05, 2018
October 5, 2018 — Leading oncology experts from around the world recently met to discuss the integration of...
Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
ViewRay Unveils New Soft Tissue Visualization Technologies for MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | April 30, 2018
ViewRay Inc. announced new magnetic resonance imaging (MRI) technologies under development for its MRIdian Linac...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.